When is the MPEP 2412.05(c) guidance on sequence variants applicable?

The guidance provided in MPEP 2412.05(c) is applicable under specific conditions:

“[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]”

This means that the requirements for representing sequence variants in the “Sequence Listing XML” apply to patent applications:

  • Filed on or after July 1, 2022
  • Containing disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b)

It’s crucial for patent applicants and examiners to be aware of this applicability date to ensure compliance with the current guidelines.

To learn more:

Topics: MPEP 2400 - Biotechnology, MPEP 2412.05(C) - Representation And Inclusion Of Variants, Patent Law, Patent Procedure
Tags: biotechnology patents, Mpep Applicability, Patent Application Date, Sequence Disclosure, sequence listing xml